About Styrax Life Sciences Private Limited
Data last updated:
Styrax Life Sciences Private Limited is a private limited company based in Anakapalle, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24232AP2014PTC093548. Its GSTIN is 37AAFCB9406R1Z0 (Andhra Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹16.4 Cr and a paid-up capital of ₹6.57 Cr. It was formerly known as Beatus Laboratories Private Limited. It is led by directors Lakshmi Devi Suryadevara and Suryadevara Venkateswara Rao.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Anakapalle, Andhra Pradesh.
As per the financials filed for FY 2023, the company reported a revenue of ₹176.27 Cr, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹8.32 Cr (net margin 4.7%) and EBITDA of ₹26.97 Cr (EBITDA margin 15.3%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years.
The company has about 202 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹234.22 Cr and satisfied charges of ₹56.92 Cr on record. Court records list 7 cases involving the company, including 2 filed by the company and 4 filed against it; 5 cases are pending. The company has 3 deals on record (3 funding rounds), with disclosed funding of ₹16.39 Cr; the latest was in February 2019.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website styraxpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No 5G Atchuthapuram, Rambilli Mandal Anakapalli, Anakapalle, Andhra Pradesh, India – 531061
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Styrax Life Sciences Private Limited FY 2024 filings available
Styrax Life Sciences Private Limited reported revenue of ₹176.27 Cr (up 39% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Styrax Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 38% over three years, including 39% growth in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Styrax Life Sciences Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹176.27 Cr | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹26.97 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8.32 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Styrax Life Sciences Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Styrax Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Styrax Life Sciences Private Limited
Styrax Life Sciences Private Limited is audited by L N P & Co for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| L N P & Co | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Styrax Life Sciences Private Limited
Styrax Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lakshmi Devi Suryadevara | Director | 14 Mar 2014 | 12 Years 6 Months | Current |
| Suryadevara Venkateswara Rao | Director | 14 Mar 2014 | 12 Years 6 Months | Current |
Ownership and Shareholding of Styrax Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Styrax Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 May 2024 | Others | ₹20 Cr | Open |
| 29 Mar 2024 | Sidbi | ₹1.65 Cr | Open |
| 04 Oct 2023 | Others | ₹36 Cr | Open |
| 30 Jun 2023 | Others | ₹6.87 Cr | Open |
| 23 Mar 2023 | Axis Bank Limited | ₹15 Cr | Open |
Total charge records: 14 View all charges
Deals & Funding of Styrax Life Sciences Private Limited
Styrax Life Sciences Private Limited has 3 deals on record (3 funding rounds), with disclosed funding of ₹16.39 Cr; the latest was in February 2019.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2019 | Funding round | ₹6.92 Cr | Investors: 2 individuals |
| Aug 2018 | Funding round | ₹2 Cr | Investors: 4 individuals |
| Aug 2018 | Funding round | ₹7.48 Cr | Investors: 2 individuals |
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Styrax Life Sciences Private Limited
Styrax Life Sciences Private Limited has 7 court cases on record: 2 filed by Styrax Life Sciences, 4 filed against it, 1 where it is another party. 5 cases are pending and 2 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 1 |
| District courts | 3 | 3 | 3 |
| Supreme Court | 1 | 1 | 1 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Indore, Madhya Pradesh | Court case (UN CIV) | Filed against the company by Agarwal Coal Corporation Private Limited | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMARY CASE) | Filed against the company by Azelis (India) Private Limited | Pending |
| District court, Visakapatnam, Andhra Pradesh | Criminal case | Filed against the company by Greenfy India | Pending |
| High Court of Andhra Pradesh | Court case (WP(PIL)) | Company is another party | Pending |
| Supreme Court | Court case | Filed against the company by Union of India | Pending |
Full case history
All 7 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Styrax Life Sciences Private Limited
Styrax Life Sciences Private Limited has a workforce of 202 employees as of Apr 05, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Styrax Life Sciences Private Limited
Styrax Life Sciences has one previous CIN (Corporate Identification Number): U24232TG2014PTC093548. The current CIN is U24232AP2014PTC093548, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232AP2014PTC093548 | Current |
| U24232TG2014PTC093548 | Previous |
Recent Activity on Styrax Life Sciences Private Limited
Styrax Life Sciences Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Lakshmi Devi Suryadevara was appointed as Director on 14 Mar 2014.
20 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Styrax Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Styrax Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Styrax Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Styrax Life Sciences Private Limited
Styrax Life Sciences has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAFCB9406R1Z0 | Andhra Pradesh | Active | 10 Nov 2017 |
| 36AAFCB9406R1Z2 | Telangana | Active | 22 Jul 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Styrax Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Styrax Life Sciences Private Limited
Styrax Life Sciences is an active private limited company based in Anakapalle, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 March 2014 (12+ years old) and is registered under CIN U24232AP2014PTC093548.
Styrax Life Sciences reported revenue of ₹176.27 Cr for FY 2023 (up 39% YoY).
Styrax Life Sciences has 2 current directors:
- Lakshmi Devi Suryadevara - Director
- Suryadevara Venkateswara Rao - Director
Styrax Life Sciences reported a net profit of ₹8.32 Cr (net margin 4.7%) and EBITDA of ₹26.97 Cr (EBITDA margin 15.3%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Styrax Life Sciences is 38% over three years. In the latest year (FY 2023) revenue rose 39%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Styrax Life Sciences is 37AAFCB9406R1Z0, registered in Andhra Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AAFCB9406R1Z2 (Telangana).
The CIN (Corporate Identification Number) of Styrax Life Sciences is U24232AP2014PTC093548. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Styrax Life Sciences has 7 court cases on record: 2 filed by the company and 4 filed against it. 5 are pending. Most are in the high courts.
Styrax Life Sciences was incorporated on 14 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Vijayawada.
Styrax Life Sciences has 3 deals on record (3 funding rounds), with disclosed funding of ₹16.39 Cr; the latest was in February 2019.